Azkarra Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 3

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 1

Azkarra General Information

Description

Operator of a therapeutics company intended to target DNA damage repair and immune response pathways. The company aims to exploit molecular targets at the intersection of DNA Damage Repair (DDR) and immune response, advancing next-generation cancer therapeutics that offer novel therapies that enhance anti-tumor immunity by discovering small molecule modulators of DDR pathways, enabling patients access to new opportunities to cancer treatment and other diseases.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 280 Utah Avenue
  • Suite 250, South
  • South San Francisco, CA 94080
  • United States
Primary Industry
Drug Discovery
Corporate Office
  • 280 Utah Avenue
  • Suite 250, South
  • South San Francisco, CA 94080
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Azkarra Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Secondary Transaction - Private Completed Pre-Clinical Trials
3. Early Stage VC (Series B) 12-Aug-2022 Completed Pre-Clinical Trials
2. Early Stage VC (Series A) $2.5M $3.2M Completed Pre-Clinical Trials
1. Seed Round $700K $700K Completed Pre-Clinical Trials
To view Azkarra’s complete valuation and funding history, request access »

Azkarra Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B
Series A
Seed-1 10,000,000 $0.000100 $0.06 $0.06 1x $0.06 15.24%
Seed 1,666,667 $0.000100 $0.06 $0.06 1x $0.06 2.54%
To view Azkarra’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Azkarra Patents

Azkarra Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20260317356-A1 Small molecule modulators of ogg1 Pending 20-Apr-2023
WO-2024220626-A1 Small molecule modulators of ogg1 Inactive 20-Apr-2023
EP-4594314-A1 Pyridazin-3(2h)-one and pyridin-2(1h)-one parp inhibitor compounds Pending 30-Sep-2022
US-20260109686-A1 Pyridazin-3(2h)-one and pyridin-2(1h)-one parp inhibitor compounds Pending 30-Sep-2022
WO-2024073133-A1 Pyridazin-3(2h)-one and pyridin-2(1h)-one parp inhibitor compounds Inactive 30-Sep-2022 C07D403/12
To view Azkarra’s complete patent history, request access »

Azkarra Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Azkarra Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Pandect Bioventures Venture Capital Minority
To view Azkarra’s complete investors history, request access »

Azkarra FAQs

  • When was Azkarra founded?

    Azkarra was founded in 2020.

  • Where is Azkarra headquartered?

    Azkarra is headquartered in South San Francisco, CA.

  • What is the size of Azkarra?

    Azkarra has 3 total employees.

  • What industry is Azkarra in?

    Azkarra’s primary industry is Drug Discovery.

  • Is Azkarra a private or public company?

    Azkarra is a Private company.

  • What is Azkarra’s current revenue?

    The current revenue for Azkarra is .

  • How much funding has Azkarra raised over time?

    Azkarra has raised $9.2M.

  • Who are Azkarra’s investors?

    Pandect Bioventures has invested in Azkarra.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process